CEACAM5 and neoplasm: A certain number of risk factors related to prognosis for metastatic CRC patients receiving PTR were proposed, such as age, preoperative carcinoembryonic antigen (CEA) level, tumor site, TNM stage, tissue differentiation, and histopathology [14–19].